A Peter Mac-led international clinical trial has found a way to personalize treatment for gastroesophageal cancer, ...

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

The “Full House” star was diagnosed with stage 3 non-Hodgkin lymphoma in October 2024 and recently concluded his final round ...

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

Corcept Therapeutics said on Monday its experimental drug in combination with chemotherapy helped delay progression of a type ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

In the interview, Coulier revealed that he recently spent multiple nights in the hospital due to a common cold that had him ...

Neal Shore, MD, FACS, discussed findings from the SunRISe-4 trial of TAR-200 and cetrelimab in muscle-invasive bladder cancer ...

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for ...

Elena Adams said she was put on temozolomide within days of being diagnosed with a brain tumour in 2016. Guidelines say the ...